Kuecept Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
14
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Kuecept General Information
Description
Operator of a contract research organization intended to help clients with experimental study design and data interpretation supporting preclinical drug development. The company provides analytical, specialist screening, preformulation and custom formulation services supporting oral and parenteral drug development.
Contact Information
Website
www.kuecept.comCorporate Office
- 16/17 Station Close
- Potters Bar EN6 1TL
- England, United Kingdom
Corporate Office
- 16/17 Station Close
- Potters Bar EN6 1TL
- England, United Kingdom
Kuecept Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kuecept Comparisons
Industry
Financing
Details
Kuecept Competitors (8)
One of Kuecept’s 8 competitors is Epo Berlin-buch, a Corporation company based in Berlin, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Epo Berlin-buch | Corporation | Berlin, Germany | ||||
| Champions Oncology | Formerly VC-backed | Hackensack, NJ | ||||
| The Emmes Company | Private Equity-Backed | Rockville, MD | ||||
| Crown Bioscience | Formerly VC-backed | San Diego, CA | ||||
| Zealand Pharma | Formerly VC-backed | Soborg, Denmark |
Kuecept Patents
Kuecept Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201307657-D0 | Micronisation process | Inactive | 26-Apr-2013 | ||
| GB-201307659-D0 | Preparation of drug particles by micronisation | Inactive | 26-Apr-2013 | ||
| WO-2014174233-A1 | Preparation of drug particles by micronisation | Inactive | 26-Apr-2013 | ||
| GB-201217234-D0 | Micronisation process | Inactive | 27-Sep-2012 | ||
| GB-201102237-D0 | Particle formulation | Inactive | 09-Feb-2011 | A61K31/192 |
Kuecept Signals
Kuecept FAQs
-
When was Kuecept founded?
Kuecept was founded in 2007.
-
Where is Kuecept headquartered?
Kuecept is headquartered in Potters Bar, United Kingdom.
-
What is the size of Kuecept?
Kuecept has 14 total employees.
-
What industry is Kuecept in?
Kuecept’s primary industry is Drug Discovery.
-
Is Kuecept a private or public company?
Kuecept is a Private company.
-
What is Kuecept’s current revenue?
The current revenue for Kuecept is .
-
Who are Kuecept’s competitors?
Epo Berlin-buch, Champions Oncology, The Emmes Company, Crown Bioscience, and Zealand Pharma are some of the 8 competitors of Kuecept.
-
When was Kuecept acquired?
Kuecept was acquired on 10-May-2016.
-
Who acquired Kuecept?
Kuecept was acquired by Aptuit.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process